Although most of the proposed mechanisms associated to the statin effects in AD are related to the cerebrovascular system, statin administration was shown to increase hepatic LRP1 expression [192], which can facilitate peripheral clearance of Aβ. The gene discussed is LRP1; the disease is Alzheimer disease.